OFCM
IMVT icon

One Fin Capital Management’s Immunovant IMVT Stock Holding History

One Fin Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-612,497
Closed -$6.47M – 24
2021
Q2 		$6.47M Buy
612,497
+60,000
+11% +$838K 2.56% 19
2021
Q1 		$8.86M Buy
+552,497
New +$14.6M 3.41% 14

Other funds holding IMVT

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

One Fin Capital Management's IMVT Position: Q3 2021 in Review

One Fin Capital Management sold out of Immunovant (IMVT) in Q3 2021, closing a stake of 612,497 shares — an estimated $6.47M sold.

One Fin Capital Management first reported a position in IMVT in Q1 2021 and held it in 2 quarters. The position peaked at $8.86M in Q1 2021. 119 funds tracked by Wall St. Rank hold IMVT as of Q3 2021.

  • One Fin Capital Management reported no remaining Immunovant position as of Q3 2021 after selling out during the quarter.
  • One Fin Capital Management sold 612,497 Immunovant shares in Q3 2021, an estimated $6.47M.
  • One Fin Capital Management first reported a position in Immunovant in Q1 2021 and held it in 2 quarters.
  • One Fin Capital Management's Immunovant position peaked at $8.86M in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Immunovant as of Q3 2021.

Based on One Fin Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.